SAT1 and glioblastoma multiforme: Disarming the resistance

Adina Brett-Morris, Mazen Mislmani, Scott M. Welford

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Glioblastoma multiforme is the most common and most detrimental form of brain tumor, with a current survival time of as little as 14 months. We have recently identified a novel mechanism of therapeutic resistance based on overexpression of the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase, which promotes DNA repair via chromatin modification.

Original languageEnglish (US)
Article numbere983393
JournalMolecular and Cellular Oncology
Issue number3
StatePublished - Jul 3 2015
Externally publishedYes


  • BRCA1
  • SAT1
  • glioblastoma
  • histone acetylation
  • radiation resistance

ASJC Scopus subject areas

  • Molecular Medicine
  • Cancer Research


Dive into the research topics of 'SAT1 and glioblastoma multiforme: Disarming the resistance'. Together they form a unique fingerprint.

Cite this